Study of Leqvio for high cholesterol in Korea
Treatments studied
Part of Heart & circulation clinical trials.
This study is for adults in Korea with high cholesterol who need a new option because statins aren't working well enough or cause side effects. It will look at how well the medication Leqvio works in everyday medical practice.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have high cholesterol (hypercholesterolemia) or a mix of high cholesterol and high fats (mixed dyslipidemia).
- Your doctor has prescribed Leqvio as a pre-filled syringe as part of your regular care.
- You cannot reach your LDL ('bad') cholesterol goal even with the highest tolerable dose of statin medication, or you cannot tolerate statins.
- You agree to take part in the study and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug (QLC7401) that may help lower LDL ('bad') cholesterol in people who already have high cholesterol or mixed hyperlipidemia. If you're on stable cholesterol medication but still need more lowering, this trial could offer another option.
This study tests a new investigational medicine (QLC7401) that aims to lower LDL ('bad') cholesterol when added to your current cholesterol-lowering therapy. If you are already on a statin but your cholesterol is still not low enough, this trial might help you reach your goals.
This trial tests a new medicine that aims to lower LDL (bad) cholesterol in healthy adults. It will help doctors understand how the medicine works in the body and how safe it is.
This trial tests a new medicine called QLC7401 to lower cholesterol in adults with high cholesterol who are not currently on cholesterol-lowering treatment. It may help reduce the risk of heart problems.
This study tests an investigational medicine called QLC7401 for people with a genetic condition called heterozygous familial hypercholesterolemia, which causes very high cholesterol. It aims to see if the new medicine can further lower bad cholesterol when added to your usual cholesterol treatments.
This trial tests a new medicine called inclisiran to lower very high cholesterol in children aged 2 to 12 who have a specific genetic condition (homozygous familial hypercholesterolemia, or HoFH). You may not need to change your current cholesterol treatments, and the study will check if inclisiran can help reduce your LDL cholesterol further.
Hear when a new Primary Hypercholesterolemia or Mixed Dyslipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.